A study links COVID-19 infection to higher ME/CFS rates, supporting Ampligen's potential as a treatment for affected individuals. AIM ImmunoTech Inc. has commented on a recently published study in the ...

Change in medicine is never easy, especially when practitioners are asked to dispense with long-held beliefs about an illness. It is this challenge—of steering an entire community to collectively ...

Postinfectious myalgic encephalomyelitis/chronic fatigue syndrome (PI-ME/CFS) is a distinct, centrally mediated condition, with evidence of autonomic, immune, and metabolic dysfunction, new "deep ...

All products featured on Self are independently selected by Self editors. However, when you buy something through our retail links, Condé Nast may earn an affiliate commission. AnnaStills/Getty Images ...

A study led by UMass Chan Medical School viral immunologists Liisa Selin, MD, PhD, and Anna Gil, PhD, discovered similarities in immune system dysfunction as a potential biomarker among people living ...

A new study has revealed that those with myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) have notable genetic differences from the general population. The DecodeME research team, led by ...

A recent CDC-funded paper in the Journal of Clinical Medicine suggests that the agency's Fukuda empirical criteria for diagnosing Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) identified ...

Fatigue in post-infectious myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may stem from dysfunction of integrative brain regions that drive the motor cortex, a deep phenotyping study ...